Next Phase Newsletter

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Happy New Year! Life Science Nation (LSN) is excited to kick off 2022 with Digital RESI JPM next week. A record number of early-stage life science and healthcare companies applied to participate in the Innovator’s Pitch Challenge (IPC) at the upcoming RESI.

Our 54 finalist companies will have a dedicated webpage that includes the company’s key marketing collateral including a short pitch video, available for viewing to all RESI attendees. Most importantly, these companies have been assigned to a 1-hour live Q&A session based on sector/technology, interacting with investors and strategic partners who will ask them targeted questions and provide feedback on their pitches.

We are delighted to feature companies across a wide variety of sectors, including therapeutics, devices, diagnostics, and digital health. See the participating companies below:

Digital RESI JPM 2022 IPC Finalists

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

It has been more than a year since we’ve introduced the Innovator’s Pitch Challenge (IPC), Life Science Nation’s latest effort to boost exposure for early-stage companies attending the Redefining Early Stage Investment (RESI) conference virtually. Since its inception, the IPC has become one of the most anticipated components of the RESI program. To date, hundreds of early-stage life science and healthcare startups and hundreds of investor and industry expert judges have participated. We are excited to continue growing this dynamic platform of companies and investors, strategic partners, industry experts, and more to facilitate new conversations.

Hear from some of these previous participants about their experience and how the IPC helped them along their fundraising journey:

We are actively accepting applications for the Digital RESI JPM Innovator’s Pitch Challenge, where we will showcase innovative technologies across therapeutics, medical devices, diagnostics/tools, and digital health.

Applications are due Friday, December 17 – it’s not too late to apply!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Today is the last day of the Digital RESI November Innovator’s Pitch Challenge. If you missed your opportunity to pitch to relevant investors seeking opportunities in your space, Digital RESI JPM, January 11-13, 2022 is right around the corner! Join us at the biggest virtual fundraising event of the year and submit your application the the Digital RESI JPM Innovator’s Pitch Challenge.

What is it?

The Innovator’s Pitch Challenge (IPC) is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session. Participating companies pay registration and a $800 pitching fee to host their company materials on the Live Agenda and participate in the live pitch session.

How Does it Work?

Pitching companies will have a dedicated webpage on the Live Agenda, which greatly increases visibility to investors. Prior to the live pitch session, the investor panel will review submitted pitch materials and prepare questions.

Each company has approximately 10 minutes set aside for their participation. Each session is judged by a panel of investors who have expressed interest in the sector(s) highlighted in the session. During the session, the pitching company delivers a brief (~1 minute) elevator pitch, and saves the rest of their time for investors’ questions, feedback and commentary. The session is open to all registered RESI attendees.

Who Should Apply?

Early-stage life science companies actively raising seed capital (25K-2MM), Series A (2MM-10MM), or Series B (10MM-50MM) use the IPC to get in front of the panel of qualified investor judges in their market segment and pitch their company and product. Early-stage companies are encouraged to submit an application, along with a pitch deck and an executive summary. Once selected to pitch, companies can submit their video and supplemental materials for investors to review prior to the live session.

By Karen Deyo, Director of Investor Research, Israel BD, LSN

Digital RESI November is not over yet but has so far been one of our most successful virtual events. With over 600 attendees from 30 countries across 5 continents, RESI continues to demonstrate how truly global Life Science Nation (LSN)’s early-stage ecosystem is. Attendees have had access to investor panels, workshops and could watch over 50 presenting companies in the Innovator’s Pitch Challenge. With two days down and one day left, over 1,000 meetings have already taken place through RESI’s unique, match-based partnering platform. With our next RESI, taking place during JP Morgan Healthcare Week, right around the corner, make sure not to miss out on the next opportunity to take part in a virtual event that truly works! Sign up by November 28 to save $300!

By Gregory Mannix, Vice President International Business Development, General Manager Europe, LSN

At Digital RESI November we will again be showcasing top technologies across Drugs, Devices, Diagnostics and Digital Health in this edition of the Innovator’s Pitch Challenge. These companies will be featured on the RESI Live Agenda and will participate in live Pitch Sessions focused on a particular sector or indication, fielding questions from a panel of selected investors and industry experts.  The IPC has grown tremendously in popularity over the past year and attracts a big virtual audience, including investors and strategic partners.

Best of luck to the finalists!!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

The Innovator’s Pitch Challenge (IPC) is a highlight at Life Science Nation events, with innovative startups in life science and healthcare pitching to investors in a live Q&A format, providing feedback, practice, and for some, valuable connections that lead to deals. The IPC returns to Digital RESI November 16-18 and there is one day left to apply at the extended deadline!

If you are involved with a company in active fundraising mode and want to boost your exposure, gain valuable feedback from investors and industry experts, and secure meetings with investors who have a genuine interest in your technology, you do not want to miss out on the last IPC of 2021!

Below is a list of companies who have been accepted as finalists – conference attendees will be able to vote for their favorite pitch.

By Megan Rychwa, Investor Research Analyst, LSN

Life Science Nation’s last conference of the year, Digital RESI November 16-18, is currently accepting applications from startup companies across the globe for the popular Innovator’s Pitch Challenge (IPC). The number of participating startups has doubled within the last year, with hundreds of companies and investors experiencing the value firsthand. Applications are accepted on a rolling basis until Friday, October 22.

The Innovator’s Pitch Challenge is an opportunity for early-stage companies to pitch to a live panel of investors within their sector. Each company’s marketing materials are highlighted on their dedicated webpage, as well as their recorded pitch, which investors can see prior to the conference in preparation for the live event. The pitch session is a unique chance for companies to gain exposure to a large investor audience and prepare those companies to build strategic partnerships with well-matched investors. The cost for IPC finalists includes event registration, as well as a $500 pitch fee.

The deadline for IPC applications is tomorrow, so make sure your application is in and you don’t miss out on this great opportunity to tell your story!